Combined Alopecia Treatment May Help Pediatric Patients
A single case report shows promising hair regrowth in a 10-year-old child using a specific alternating injection protocol.
Updated on Oct. 28, 2026 in Allergies
A 10-year-old patient achieved full hair regrowth after receiving alternating platelet-rich plasma and corticosteroid injections over 162 days. This clinical finding was presented in October 2026 as a potential approach for pediatric alopecia management.
Why it matters
Managing pediatric hair loss can be challenging, and this combined treatment aims to leverage both regenerative and anti-inflammatory properties to restore hair. Because this result is based on a single case report, it serves as a starting point for further investigation rather than a confirmed standard of care.
A case report of a 10-year-old boy showed a reduction in the Severity of Alopecia Tool score from 89.4% to 0% after 162 days of treatment. As this is a single case, the results are preliminary and require further clinical trials to validate.
The players
Skin of Color Update
A professional medical conference focusing on dermatological conditions and therapeutic advancements for diverse skin and hair types.
The details
The treatment protocol involved intradermal platelet-rich plasma and intralesional triamcinolone acetonide injections at a concentration of 5 mg/mL, administered every 14 days. The approach works by combining the regenerative potential of growth factors in platelet-rich plasma with the anti-inflammatory effects of corticosteroids to address hair loss. No systemic side effects, skin atrophy, or pigmentary changes were reported during the course of the six sessions for each treatment type.
Timeline
The 162-day treatment program concluded following 12 total sessions.
The findings were presented at the Skin of Color Update on October 9-11, 2026.
Health Landscape
This case report contributes to a growing body of research exploring the use of platelet-rich plasma in dermatology. It builds upon findings established in the 2022 systematic review and meta-analysis of PRP treatments by specifically investigating its role in a pediatric setting.
If you are managing alopecia in a child, it is worth discussing with your dermatologist whether combined therapies are appropriate for your specific case. Because this treatment approach remains preliminary, seek a provider who can evaluate the risks and benefits relative to existing pediatric care.
The takeaway
While this pediatric case shows positive results for combined injections, it remains a single clinical example rather than a validated treatment protocol. Parents should consult a specialist to discuss evidence-based options and monitor for any side effects when exploring emerging dermatological therapies.
Further reading
For more information on managing hair loss conditions, visit our section on Allergies.
Source note: This article includes information reported by Ajmc.
